# A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.

> **NCT06512116** · PHASE1 · RECRUITING · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 196 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SIBP-A17

## Key facts

- **NCT ID:** NCT06512116
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-23
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06512116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06512116, "A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06512116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*